Person

Eric K. Rowinsky

Director, Biogen

Current S&P 500 boards
1
Current roles
1
Open-market buys
$101K
Open-market sales
$0

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Feb 15, 2024BIIBBuy455$222.54$101K

SEC reporting-owner ID (CIK) 1318886 · all filings on EDGAR

Eric K. Rowinsky (BIIB) | USBoard